230 related articles for article (PubMed ID: 23826971)
1. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics.
Muthiah M; Park IK; Cho CS
Expert Opin Drug Deliv; 2013 Sep; 10(9):1259-73. PubMed ID: 23826971
[TBL] [Abstract][Full Text] [Related]
2. Polyethylenimines for siRNA and miRNA delivery in vivo.
Höbel S; Aigner A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
[TBL] [Abstract][Full Text] [Related]
3. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-targeted therapeutics for lung cancer treatment.
Xue J; Yang J; Luo M; Cho WC; Liu X
Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
[TBL] [Abstract][Full Text] [Related]
5. Strategies to antagonize miRNA functions in vitro and in vivo.
Baigude H; Rana TM
Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
[TBL] [Abstract][Full Text] [Related]
6. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
Weirauch U; Gutsch D; Höbel S; Aigner A
Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
[TBL] [Abstract][Full Text] [Related]
7. Exploring the interaction between small RNAs and R genes during Brachypodium response to Fusarium culmorum infection.
Lucas SJ; Baştaş K; Budak H
Gene; 2014 Feb; 536(2):254-64. PubMed ID: 24368332
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
Kaucsár T; Rácz Z; Hamar P
Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-mediated delivery of microRNAs-based therapies for treatment of disorders.
Ghafouri-Fard S; Shoorei H; Noferesti L; Hussen BM; Moghadam MHB; Taheri M; Rashnoo F
Pathol Res Pract; 2023 Aug; 248():154667. PubMed ID: 37422972
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers for microRNA delivery.
Scheideler M; Vidakovic I; Prassl R
Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale delivery systems for microRNAs in cancer therapy.
Boca S; Gulei D; Zimta AA; Onaciu A; Magdo L; Tigu AB; Ionescu C; Irimie A; Buiga R; Berindan-Neagoe I
Cell Mol Life Sci; 2020 Mar; 77(6):1059-1086. PubMed ID: 31637450
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
Zhao J; Feng SS
Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
14. Vectors and methods for hairpin RNA and artificial microRNA-mediated gene silencing in plants.
Eamens AL; Waterhouse PM
Methods Mol Biol; 2011; 701():179-97. PubMed ID: 21181531
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
16. Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.
Ahmadzada T; Reid G; McKenzie DR
Biophys Rev; 2018 Feb; 10(1):69-86. PubMed ID: 29327101
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated small RNA delivery for gene therapy.
Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
[TBL] [Abstract][Full Text] [Related]
18. Exploiting microRNAs As Cancer Therapeutics.
Robb T; Reid G; Blenkiron C
Target Oncol; 2017 Apr; 12(2):163-178. PubMed ID: 28138797
[TBL] [Abstract][Full Text] [Related]
19. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
Joo MK; Yhee JY; Kim SH; Kim K
J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as new therapeutic targets and tools in cancer.
Gandellini P; Profumo V; Folini M; Zaffaroni N
Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
